Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation

B. Wilken, P. Dechent, K. Brockmann, J. Finsterbusch, M. Baumann, W. Ebell, G. C. Korenke, P. J.W. Pouwels, F. A. Hanefeld, Jens Frahm

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

About 35-40% of boys with X-linked adrenoleukodystrophy (ALD) develop a rapidly progressive cerebral form which leads to severe neurologic disability and death within 3-5 years after onset of clinical symptoms. Because previous proton magnetic resonance spectroscopy (MRS) studies of ALD identified metabolite patterns characteristic of demyelination, gliosis, and neuroaxonal loss, this work tested the hypothesis that MRS - apart from indicating disease progression - provides criteria for the outcome after hematopoietic stem cell transplantation (HSCT) which has been promising at an early stage of the active disease. Follow-up quantitative proton MRS was performed in frontal and occipital white matter of ALD patients (n = 12) before and up to 5 years after HSCT. The observed metabolite alterations were retrospectively correlated with the clinical outcome representing either a stable condition (n = 5), a further deterioration (n = 5), or death (n = 2). While disease progression of patients before HSCT was mainly characterized by a further increase of elevated choline-containing compounds (Cho) as an indicator of active demyelination, a positive outcome after HSCT was correlated with high N-acetylaspartate (tNAA) levels in affected white matter before HSCT yielding positive and negative predictive values for tNAA of 80%. Although to be confirmed in a larger cohort of patients, the present findings suggest the preservation of neuroaxonal integrity as a prerequisite for an arrested course. Conversely, the combination of increased Cho with markedly reduced tNAA before HSCT apparently reflects a degree of tissue degeneration which precludes a successful therapeutic intervention.

Original languageEnglish
Pages (from-to)237-246
Number of pages10
JournalNeuropediatrics
Volume34
Issue number5
DOIs
Publication statusPublished - 1 Oct 2003
Externally publishedYes

Cite this

Wilken, B. ; Dechent, P. ; Brockmann, K. ; Finsterbusch, J. ; Baumann, M. ; Ebell, W. ; Korenke, G. C. ; Pouwels, P. J.W. ; Hanefeld, F. A. ; Frahm, Jens. / Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation. In: Neuropediatrics. 2003 ; Vol. 34, No. 5. pp. 237-246.
@article{5dd5c44bcb4940f5ad9c19e532945cd8,
title = "Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation",
abstract = "About 35-40{\%} of boys with X-linked adrenoleukodystrophy (ALD) develop a rapidly progressive cerebral form which leads to severe neurologic disability and death within 3-5 years after onset of clinical symptoms. Because previous proton magnetic resonance spectroscopy (MRS) studies of ALD identified metabolite patterns characteristic of demyelination, gliosis, and neuroaxonal loss, this work tested the hypothesis that MRS - apart from indicating disease progression - provides criteria for the outcome after hematopoietic stem cell transplantation (HSCT) which has been promising at an early stage of the active disease. Follow-up quantitative proton MRS was performed in frontal and occipital white matter of ALD patients (n = 12) before and up to 5 years after HSCT. The observed metabolite alterations were retrospectively correlated with the clinical outcome representing either a stable condition (n = 5), a further deterioration (n = 5), or death (n = 2). While disease progression of patients before HSCT was mainly characterized by a further increase of elevated choline-containing compounds (Cho) as an indicator of active demyelination, a positive outcome after HSCT was correlated with high N-acetylaspartate (tNAA) levels in affected white matter before HSCT yielding positive and negative predictive values for tNAA of 80{\%}. Although to be confirmed in a larger cohort of patients, the present findings suggest the preservation of neuroaxonal integrity as a prerequisite for an arrested course. Conversely, the combination of increased Cho with markedly reduced tNAA before HSCT apparently reflects a degree of tissue degeneration which precludes a successful therapeutic intervention.",
keywords = "Childhood adrenoleukodystrophy, Demyelination, Magnetic resonance spectroscopy, Neurodegeneration",
author = "B. Wilken and P. Dechent and K. Brockmann and J. Finsterbusch and M. Baumann and W. Ebell and Korenke, {G. C.} and Pouwels, {P. J.W.} and Hanefeld, {F. A.} and Jens Frahm",
year = "2003",
month = "10",
day = "1",
doi = "10.1055/s-2003-43254",
language = "English",
volume = "34",
pages = "237--246",
journal = "Neuropediatrics",
issn = "0174-304X",
publisher = "Hippokrates Verlag GmbH",
number = "5",

}

Wilken, B, Dechent, P, Brockmann, K, Finsterbusch, J, Baumann, M, Ebell, W, Korenke, GC, Pouwels, PJW, Hanefeld, FA & Frahm, J 2003, 'Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation' Neuropediatrics, vol. 34, no. 5, pp. 237-246. https://doi.org/10.1055/s-2003-43254

Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation. / Wilken, B.; Dechent, P.; Brockmann, K.; Finsterbusch, J.; Baumann, M.; Ebell, W.; Korenke, G. C.; Pouwels, P. J.W.; Hanefeld, F. A.; Frahm, Jens.

In: Neuropediatrics, Vol. 34, No. 5, 01.10.2003, p. 237-246.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation

AU - Wilken, B.

AU - Dechent, P.

AU - Brockmann, K.

AU - Finsterbusch, J.

AU - Baumann, M.

AU - Ebell, W.

AU - Korenke, G. C.

AU - Pouwels, P. J.W.

AU - Hanefeld, F. A.

AU - Frahm, Jens

PY - 2003/10/1

Y1 - 2003/10/1

N2 - About 35-40% of boys with X-linked adrenoleukodystrophy (ALD) develop a rapidly progressive cerebral form which leads to severe neurologic disability and death within 3-5 years after onset of clinical symptoms. Because previous proton magnetic resonance spectroscopy (MRS) studies of ALD identified metabolite patterns characteristic of demyelination, gliosis, and neuroaxonal loss, this work tested the hypothesis that MRS - apart from indicating disease progression - provides criteria for the outcome after hematopoietic stem cell transplantation (HSCT) which has been promising at an early stage of the active disease. Follow-up quantitative proton MRS was performed in frontal and occipital white matter of ALD patients (n = 12) before and up to 5 years after HSCT. The observed metabolite alterations were retrospectively correlated with the clinical outcome representing either a stable condition (n = 5), a further deterioration (n = 5), or death (n = 2). While disease progression of patients before HSCT was mainly characterized by a further increase of elevated choline-containing compounds (Cho) as an indicator of active demyelination, a positive outcome after HSCT was correlated with high N-acetylaspartate (tNAA) levels in affected white matter before HSCT yielding positive and negative predictive values for tNAA of 80%. Although to be confirmed in a larger cohort of patients, the present findings suggest the preservation of neuroaxonal integrity as a prerequisite for an arrested course. Conversely, the combination of increased Cho with markedly reduced tNAA before HSCT apparently reflects a degree of tissue degeneration which precludes a successful therapeutic intervention.

AB - About 35-40% of boys with X-linked adrenoleukodystrophy (ALD) develop a rapidly progressive cerebral form which leads to severe neurologic disability and death within 3-5 years after onset of clinical symptoms. Because previous proton magnetic resonance spectroscopy (MRS) studies of ALD identified metabolite patterns characteristic of demyelination, gliosis, and neuroaxonal loss, this work tested the hypothesis that MRS - apart from indicating disease progression - provides criteria for the outcome after hematopoietic stem cell transplantation (HSCT) which has been promising at an early stage of the active disease. Follow-up quantitative proton MRS was performed in frontal and occipital white matter of ALD patients (n = 12) before and up to 5 years after HSCT. The observed metabolite alterations were retrospectively correlated with the clinical outcome representing either a stable condition (n = 5), a further deterioration (n = 5), or death (n = 2). While disease progression of patients before HSCT was mainly characterized by a further increase of elevated choline-containing compounds (Cho) as an indicator of active demyelination, a positive outcome after HSCT was correlated with high N-acetylaspartate (tNAA) levels in affected white matter before HSCT yielding positive and negative predictive values for tNAA of 80%. Although to be confirmed in a larger cohort of patients, the present findings suggest the preservation of neuroaxonal integrity as a prerequisite for an arrested course. Conversely, the combination of increased Cho with markedly reduced tNAA before HSCT apparently reflects a degree of tissue degeneration which precludes a successful therapeutic intervention.

KW - Childhood adrenoleukodystrophy

KW - Demyelination

KW - Magnetic resonance spectroscopy

KW - Neurodegeneration

UR - http://www.scopus.com/inward/record.url?scp=10744220226&partnerID=8YFLogxK

U2 - 10.1055/s-2003-43254

DO - 10.1055/s-2003-43254

M3 - Article

VL - 34

SP - 237

EP - 246

JO - Neuropediatrics

JF - Neuropediatrics

SN - 0174-304X

IS - 5

ER -